O-GlucNAcase inhibitors (Nankai University)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameO-GlucNAcase inhibitors (Nankai University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNankai University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNankai University
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A